TCIM
GTHX

TIAA CREF Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

TIAA CREF Investment Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$608K Buy
36,600
+4,381
+14% +$83.1K ﹤0.01% 2525
2018
Q4 		$617K Sell
32,219
-1,014
-3% -$38K ﹤0.01% 2479
2018
Q3 		$1.74M Sell
33,233
-3,400
-9% -$185K ﹤0.01% 2195
2018
Q2 		$1.59M Buy
36,633
+9,250
+34% +$396K ﹤0.01% 2290
2018
Q1 		$1.01M Buy
27,383
+9,899
+57% +$264K ﹤0.01% 2435
2017
Q4 		$347K Sell
17,484
-990
-5% -$21.3K ﹤0.01% 2905
2017
Q3 		$460K Buy
+18,474
New +$341K ﹤0.01% 2862

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

TIAA CREF Investment Management's GTHX Position: Q1 2019 in Review

TIAA CREF Investment Management increased its G1 Therapeutics, Inc. Common Stock (GTHX) stake by 14% in Q1 2019, buying an estimated $83.1K and bringing the position to 36,600 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #2525.

TIAA CREF Investment Management first reported a position in GTHX in Q3 2017 and has held it in 7 quarters since. The position peaked at $1.74M in Q3 2018. 93 funds tracked by Wall St. Rank hold GTHX as of Q1 2019.

  • TIAA CREF Investment Management held 36,600 shares of G1 Therapeutics, Inc. Common Stock worth $608K as of Q1 2019.
  • TIAA CREF Investment Management bought 4,381 G1 Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $83.1K.
  • G1 Therapeutics, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2525 holding.
  • TIAA CREF Investment Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2017 and has held it in 7 quarters since.
  • TIAA CREF Investment Management's G1 Therapeutics, Inc. Common Stock position peaked at $1.74M in Q3 2018.
  • 93 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.